Spectral Medical (EDT) Stock Price, News & Analysis

Company Overview

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

Key Stats

• Today's Range: C$0.50 to C$0.52
• 50-Day Range: C$0.50 to C$0.67
• 52-Week Range: C$0.37 to C$0.75
• Volume: 338,903 shs
• Average Volume: 82,471 shs
• Market Capitalization: C$140.63 million
• P/E Ratio: N/A
• Dividend Yield: 1.45%
• Price Target: N/A
• Consensus Rating: N/A

EDT Stock Analysis - Frequently Asked Questions

How have EDT shares performed this year?

Spectral Medical's stock was trading at C$0.43 at the beginning of 2024. Since then, EDT stock has increased by 17.6% and is now trading at C$0.50.
View the best growth stocks for 2024 here.

How were Spectral Medical's earnings last quarter?

Spectral Medical Inc. (TSE:EDT) released its quarterly earnings data on Friday, November, 8th. The company reported ($0.04) earnings per share for the quarter. The business earned $0.50 million during the quarter.

How do I buy shares of Spectral Medical?

Shares of EDT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of Spectral Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Spectral Medical investors own include Oncolytics Biotech (ONC), Aurora Cannabis (ACB), Alamos Gold (AGI), BlackBerry (BB), Ballard Power Systems (BLDP), CENTRIC HEALTH (CHH) and Cequence Energy Ltd. (CQE.TO) (CQE).

Company Calendar

• Last Earnings: 11/08/2024
• Today: 11/22/2024
• Next Earnings (Estimated): 3/27/2025

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Diagnostics & Research
• Sub-Industry: N/A
• Current Symbol: TSE:EDT
• Previous Symbol: TSE:SDI
• CUSIP: N/A
• CIK: N/A
• Web: www.spectraldx.com
• Phone: +1-416-6263233
• Fax: N/A
• Employees: 29
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): C($0.07)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: C$-18,680,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -973.97%
• Return on Assets: -93.22%

Debt

• Debt-to-Equity Ratio: 26.03
• Current Ratio: 0.61
• Quick Ratio: 0.45

Sales & Book Value

• Annual Sales: C$1.90 million
• Price / Sales: 74.01
• Cash Flow: C$0.01 per share
• Price / Cash Flow: 82.50
• Book Value: C($0.08) per share
• Price / Book: -6.25

Miscellaneous

• Outstanding Shares: 281,250,000
• Free Float: N/A
• Market Cap: C$140.63 million
• Optionable: Not Optionable
• Beta: 0.96